Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 117 Colonic Neoplasms 30 Neoplasm Metastasis 28 Rectal Neoplasms 27 Neoplasms 27 Carcinoma, Non-Small-Cell Lung 14 Esophageal Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 9 Pancreatic Neoplasms 9 Head and Neck Neoplasms 9 Lung Neoplasms 8 Cholangiocarcinoma 7 Colorectal Cancer Metastatic 6 Carcinoma, Squamous Cell 6 Breast Neoplasms 6 Carcinoma 5 Triple Negative Breast Neoplasms 4 Recurrence 4 Prostatic Neoplasms 4 Ovarian Neoplasms 4 Inflammatory Breast Neoplasms 3 Gastrointestinal Neoplasms 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Solid Tumors 2 Kidney Neoplasms 2 Glioma 2 Fallopian Tube Neoplasms 2

Interventions

Cisplatin 116 Radiotherapy 84 Paclitaxel 77 Fluorouracil 62 Carboplatin 41 Drug Therapy 38 pembrolizumab 33 Irinotecan 33 tislelizumab 27 Docetaxel 26 Neoadjuvant Therapy 24 Oxaliplatin 23 toripalimab 22 sintilimab 19 camrelizumab 19 Radiation 19 Esophagectomy 18 Capecitabine 17 130-nm albumin-bound paclitaxel 17 Surgical Procedures, Operative 16 Nivolumab 16 Leucovorin 15 Cetuximab 14 TP protocol 12 S 1 (combination) 12 Radiotherapy, Intensity-Modulated 12 Albumin-Bound Paclitaxel 12 nimotuzumab 11 apatinib 10 Immune Checkpoint Inhibitors 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Panitumumab × Clear all

NCT01627379 2018-03-02

POWER

AIO-Studien-gGmbH

Phase 3 Terminated

Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡